Webinar: How FinTech Accelerates Growth in Early Life Sciences Companies
The journey of healthcare startups is not for cowardice. Browse the path to showcase proof of concept, find stakeholders to advocate for their mission, and generate investments to take effective communication, management and workflow efficiency.
Sign up today and become part of our discussion, we will explore how the banking platform approach becomes a resource for entrepreneurial needs across biotechnology, diagnostics and other life science companies. The journey from R&D to FDA-approved Biology can take 10 years or more. Long-term success usually depends on the earliest stages to get things right. The company must invest in regulatory expertise at the earliest stages, building a team that balances scientific expertise with business acumen.
On May 8, at 1 p.m. ET, a webinar hosted by Mercury’s healthcare and life sciences director Ben Kromnick will include these topics and more:
- With the cuts in NIH grants, what are the opportunities for private institutions to step in?
- How to develop a strategy to evaluate angel investors, SBIR grants and strategic investors
- The trend of decreasing government investment in R&D and the rise of AI challenges and opportunities for companies – how do they manage them?
- Mercury's role in helping companies pose financial challenges from the financial challenges required by any company's financial workflow, enabling them to clearly understand and access the HLS financial markets through their ecosystem and expertise.
- How Mercury works with life science incubators and accelerators such as mass challenge and cancer X
To sign up for this webinar, fill out the following form:
Mercury is a financial technology company, not a bank. Choose the banking service provided by f
